LYRA   $0.1832  0.22% Market Closed

Lyra Therapeutics, Inc.
Total Cash 67.50M
totalCashPerShare 1.031
EBITDA -74.33M
Total Debt 36.75M
quickRatio 3.502
currentRatio 3.602
Total Revenue 1.82M
debtToEquity 118.63
Revenue/Share 0.029
ROA -0.42356
ROE -1.56522
grossProfits
freeCashflow -40.52M
operatingCashflow -75.61M
earningsGrowth
revenueGrowth 0.306
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins -29.77425
profitMargins 0.0
enterpriseValue -13.24M
forwardPE -0.37824327
floatShares 41.71M
sharesOutstanding 65.46M
sharesShort 2.14M
sharesShortPriorMonth 3.14M
dateShortInterest
sharesPercentSharesOut 0.03%
heldPercentInsiders 0.01%
heldPercentInstitutions 0.58%
Short Ratio help_outline 3.65%
shortPercentOfFloat 0.04%
impliedSharesOutstanding
bookValue 0.473
Price To Book help_outline 0.59
earningsQuarterlyGrowth
netIncomeToCommon -101.39M
trailingEps -1.56%
forwardEps -0.74%
enterpriseToEbitda 0.18
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.23 3Q 2024
institutionsCount 72
lastUpdated Nov. 7, 2024, 3:14 a.m.